Search research articles
Contact Us
Filters
Showing results (41-50 of 119) with videos related to
Page
of 12
Sort By:
Plos One
|
April 13, 2011
Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?
Jens Kelsen, Anders Dige, Heinrich Schwindt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 4, 2018
Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
Jonathan J Russin, Axel Montagne, Francesco D'Amore, et al.
Cancers
|
March 10, 2022
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients
Marie Beck Enemark, Trine Engelbrecht Hybel, Charlotte Madsen, et al.
Haematologica
|
April 6, 2006
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma
Martin Hutchings, Annika Loft, Mads Hansen, et al.
Cancers
|
January 27, 2021
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
Heli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, et al.
Oncotargets and Therapy
|
January 27, 2021
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation
Marie Beck Enemark, Ida Monrad, Charlotte Madsen, et al.
Clinical Imaging
|
June 10, 2014
Diffusion restriction in a non-enhancing metastatic brain tumor treated with bevacizumab - recurrent tumor or atypical necrosis?
Lakshmanan Sivasundaram, Saman Hazany, Naveed Wagle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2008
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop
Pier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, et al.
Leukemia & Lymphoma
|
December 3, 2024
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity
Maja Dam Andersen, Katharina Wolter, Marie Hairing Enemark, et al.
Blood Advances
|
January 4, 2018
High proportions of PD-1<sup>+</sup> and PD-L1<sup>+</sup> leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 119) with videos related to
Sort By:
Page
of 12
Plos One
|
April 13, 2011
Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?
Jens Kelsen, Anders Dige, Heinrich Schwindt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 4, 2018
Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
Jonathan J Russin, Axel Montagne, Francesco D'Amore, et al.
Cancers
|
March 10, 2022
Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients
Marie Beck Enemark, Trine Engelbrecht Hybel, Charlotte Madsen, et al.
Haematologica
|
April 6, 2006
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma
Martin Hutchings, Annika Loft, Mads Hansen, et al.
Cancers
|
January 27, 2021
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
Heli Vajavaara, Julie Bondgaard Mortensen, Suvi-Katri Leivonen, et al.
Oncotargets and Therapy
|
January 27, 2021
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation
Marie Beck Enemark, Ida Monrad, Charlotte Madsen, et al.
Clinical Imaging
|
June 10, 2014
Diffusion restriction in a non-enhancing metastatic brain tumor treated with bevacizumab - recurrent tumor or atypical necrosis?
Lakshmanan Sivasundaram, Saman Hazany, Naveed Wagle, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2008
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop
Pier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, et al.
Leukemia & Lymphoma
|
December 3, 2024
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity
Maja Dam Andersen, Katharina Wolter, Marie Hairing Enemark, et al.
Blood Advances
|
January 4, 2018
High proportions of PD-1<sup>+</sup> and PD-L1<sup>+</sup> leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, et al.
Page
of 12